$POET
相关推文
共 168 条 · 按时间倒序 · 滚到底自动加载更多
-
总结SIVE基本面，批评其沟通策略，看好其作为CPO激光供应商的高增长潜力。
以下是我对 $SIVE 来自 ER 的观点与基本面的最终总结： 2027年可插拔光模块（1.6T 爬坡）： - $JBL（1.6T LRO，已确认）2027年上半年订单，下半年爬坡 -> -> 可能有多家超大规模云厂商客户 - 3家可插拔制造商（评估中） - 3家可插拔制造商（供应评估中） 2027年下半年至2028年+的参考设计： - $GFS（格芯）SCALE（已确认） -> -> 可能包括 $AMD 和其他超大规模云厂商作为共封装光学(CPO)客户 2027年外部光源/光引擎： - $POET（已确认） -> -> Lumilens / 超大规模云厂商终端用户 - O-Net（已确认） -> -> 超大规模云厂商+亚洲地区的巨大ODM/OEM - 可能包括 $AEVA（映射） -> -> 向光引擎供应 -> 超大规模云厂商/激光雷达 - SemiNex（已确认） 2028年光I/O： - Ayar Labs（已确认） -> -> 可能包括 $AMD、ALchip 和超大规模云厂商ASIC项目终端用户 + $NVDA NVLink - $MRVL Celestial（2023-2024年披露的潜在客户） - Lightmatter（2023-2024年披露的潜在客户） - Lightelligence（2023-2024年披露的潜在客户） 随后可能在2028年为 $AAPL 下一代可穿戴设备更新及其他来自 TFLN 与 Lightium 的项目供货。 关于产能分配： - Win Semi - 1家其他晶圆厂（拥有巨大分配量） 在磷化铟(InP)连续波(CW)DFB激光器短缺期间。 这些都是持续的发展/资格认证，因为 Sivers 正瞄准2027-2028年的下一代硅光(SiPH)+CW以及1.6T和CPO。 尤其是高盛模型显示CPO机会将从目前的近乎零增长到2028年约910亿美元的市场规模(TAM)。 然而我的批评是： => 主要焦点未向西方受众传达2027-2028年光学爬坡的经济规模。 => 应停止围绕纳斯达克上市的模糊法律帖子，并设定明确方向+更快执行。 => 过多关注于辩护较小的当前收入/过去十二个月(TTM)收入/管道转化（allspace, Tachyon），相对于未来的资格/合作伙伴规模/产能/潜力。 $SIVE 需要将自己定位为一家面向未来的、全球高增长的光学公司，为超大规模云厂商项目供应激光器。 不要让叙事被向后看的指标主导。 正如摩根士丹利所言……“关键[CPO]参与者包括……$LITE、$COHR 和 Sivers 激光供应”。 我个人是 $SIVE 的愉快股东，以高贝塔值暴露于2027-2028年的1.6T/CPO光学变革。
英文原文
Just my final recap on thoughts + fundamentals of $SIVE from ER: Pluggables (1.6T Ramp) for 2027: - $JBL (1.6T LRO, confirmed) Orders H1 2027, Ramp H2 2027 -> -> Likely multiple hyperscaler customers - 3 pluggable makers (evaluation) - 3 pluggable makers (supply assessment) Reference Design for likely H2 2027–28+: - $GFS (Globalfoundries) SCALE (confirmed)) -> -> Likely $AMD and other hyperscalers as CPO customers External Light Sources / Optical Engines for 2027: - $POET (confirmed) -> -> Lumilens / hyperscaler end users - O-Net (confirmed) -> -> Massive ODM/OEM for Hyperscalers + Asia - Likely $AEVA (mapping) -> -> supplying to OE -> hyperscalers / lidar - SemiNex (confirmed) Optical I/O for 2028: - Ayar Labs (confirmed) -> -> Likely $AMD, ALchip, and hyperscaler ASIC program end users + $NVDA NVLink - $MRVL Celestial (potential customer from 2023-2024 disclosures) - Lightmatter (potential customer from 2023-2024 disclosures) - Lightelligence (potential customer from 2023-2024 disclosures) Then potentially $AAPL for 2028 for next-generation wearable updates and other programs from TFLN with Lightium. In terms of capacity allocations: - Win Semi - 1 other foundry (with tremendous allocations) during an InP CW DFB laser shortage. These are all on-going developments/qualifications since Sivers is targeting next-generation SiPH + CW with 1.6T and CPO for 2027-2028. Especially as Goldman Sachs models the CPO opportunity going from effectively near-zero today to ~$91B TAM by 2028. However my criticisms were: => Main focus was not on communicating economic scale of 2027-2028 optical ramps to Western audiences. => Legal vagueposts around NASDAQ listing should be dropped, and clear direction should be set + executed faster on. =>Too much focus was put on defending smaller current revenue/TTM revenue/pipeline conversion (allspace, Tachyon.) relative to future qualifications/partner size/capacity/potential. $SIVE needs to position themselves as a forward looking, global hypergrowth optical company supplying lasers to hyperscaler programs. And not let the narrative get dominated by backward looking metrics. And as Morgan Stanley put it... "Key [CPO] participants include … $LITE, $COHR, and Sivers laser supply". I'm personally a happy $SIVE shareholder for high-beta exposure to the next 2027-2028 optical shift with 1.6T/CPO.
-
Sivers凭借激光器产能优势，在供应短缺中获大厂青睐，前景看好。
我看待 $SIVE 的角度如下： 公司/云服务提供商(CSP) 不遗余力地锁定光模块用 CW 激光器产能。 因此，Sivers 带着以下优势进入行业： - 来自 Win Semi 的大规模产能 - 来自新晶圆厂（可能自 2024 年起已进行资格认证）的“目前可用的巨大产能”，因其已合作“一段时间” 此次财报中让我兴奋的是“6 个可插拔/模块”项目（数量巨大）。 我解读的细微差别是： - $COHR 称因内部光模块需求耗尽所有产能，短期内无法对外销售 InP 激光器 - $AAOI 也表示内部消耗了激光器产能（此前并非主要独立供应商） - $LITE 受瓶颈限制，一直在公开市场购买激光器 你之前的独立供应商已将激光器产能转向内部。 因此许多大厂（如 Eoptolink/Innolight 仅为举例）可能正寻求更多激光器来源。 这也符合“具备快速资格认证和爬坡能力”的说法（这与 Series B 初创企业不符）... 很多人问为什么没有到 2030 年的长期协议(LTA)？ -> 你无法随意绕过成熟玩家已完成的资格认证流程。 为何不披露客户？ 正如 $MRVL + $POET 合作所示，你不能随意披露合作供应商。 但“12 亿美元机会管道”几乎翻倍，相对于 $JBL + $GFS 的增幅。这信号表明新的可插拔项目可能比 Jabil 更实质。 因此，如果 $SIVE 在供应短缺期间带来海量 CW DFB 激光器产能... 行业条件已发生重大变化，提高了项目转化率。 加上所有~估算客户 jabil, globalfoundries, poet, aeva, lightium, ayar, (可能 lightmatter, celestial, lightelligence), 6 家其他可插拔玩家等。 我认为连点成线后，Sivers 将大获成功。
英文原文
Here's the angle I'm looking at $SIVE at: Companies/CSPs have been going out of their way way to lock up any qualified CW laser capacity for optical transceivers. So now, Sivers is coming into the industry with: - Large capacity from Win Semi - "tremendous capacity that is available now" from a new foundry (likely qualifications since 2024) since it's engaged "for a while" And what excited me from this earnings was the "6 pluggable/module" engagements (which is an enormous amount). The nuance I'm reading is: - $COHR said it sees no near term ability to sell InP lasers externally because internal transceiver demand consumes all available - $AAOI said the same about consuming laser capacity internally (wasn't a major merchant supplier before though). - $LITE has been bottlenecked and been buying lasers off the open market Your previous merchant players rerouted laser capacity internally. So a lot of the bigger names (eg. Eoptolink/Innolight as just a random example) are probably looking to source more lasers. And that kinda matches the quote "capable of very rapid qualification and ramp" (which would not match Series B startup)... Lot of people are asking why aren't there LTAs to 2030 then? -> You can't just randomly escape the qualification process that established players have already completed. Why aren't the customers disclosed? And as seen with the $MRVL + $POET engagement, you can't just disclose the vendors you're working with. But the "$1.2B opportunity pipeline" almost doubled relative to the jump of $JBL + $GFS. So it's signals that the new pluggable engagements might be pretty substantial relative to Jabil. So if $SIVE comes along with enormous amounts of CW DFB laser capacity during a supply shortage... The industry conditions have changed in a major way that increases conversion rates of engagements. And with the sheer size from all your ~est. customers jabil, globalfoundries, poet, aeva, lightium, ayar, (maybe lightmatter, celestial, lightelligence), 6 other pluggable players, and others. I think Sivers is going to cook after connecting the dots.
-
博主认为 $SIVE 凭借广泛的光子学客户验证和稀缺产能，是极具性价比的首选标的。
不，$SIVE 是我见过的最独特的 10 亿美元市值光子学公司。仅针对 AI 数据中心： - 为 $GFS SCALE（共封装光学(CPO)/近封装光学(NPO)/可插拔模块）提供参考激光器 - 披露了 7 项可插拔模块合作，其中 $JBL 为主要放量客户（H1 2027 时间表） - 与 O-Net 的外部激光源(ELS)路径 - 与 $POET 的 ELS 路径 - 向 Ayar 提供用于 CPO I/O 的激光器（现属 $NVDA nvlink 生态系统） - 为 $AEVA 提供激光器（其已与超大规模云厂商的光引擎供应商达成 NPO 协议） - Celestial/Lightmatter/Lightelligence（可能是 2023/2024 年的客户） - 与 Lightium 合作在薄膜铌酸锂(TFLN)上集成磷化铟(InP)激光器 此外，它在行业短缺期间拥有两项实质性的连续波分布反馈(CW DFB)激光器产能分配。也是业内少数几家 CPO 级激光器供应商之一。告诉我这个市值范围内还有哪家拥有如此多的持续资格认证、巨大的潜在市场(TAM)且身处光子学领域。就相对于行业内的资格认证路径而言，$SIVE 是我心中的第一选择。
英文原文
Nah, $SIVE is the most unusual $1B photonics company I've ever seen. Just for AI DCs alone: - Reference laser for $GFS SCALE (CPO/NPO/pluggable) - 7 pluggable engagements disclosed, with $JBL as primary ramp (with H1 2027 timeline) - ELS path with O-Net - ELS path with $POET - Lasers to Ayar for CPO I/O (now in $NVDA nvlink ecosystem) - Lasers for $AEVA (which now has NPO agreements with optical engine providers for hyperscalers) - Celestial/Lightmatter/Lightelligence (likely customers in 2023/2024) - InP lasers on TFLN with Lightium Then it has 2 substantial allocations for CW DFB laser capacity during an industry shortage. As well as one of the few CPO-grade laser suppliers out in the industry. Let me know what other player around this range has so many ongoing qualifications, a large TAM, and in photonics. $SIVE is the #1 for me in terms of MC relative to qualifications paths across the industry.
-
CW激光器瓶颈持续，多厂商产能与新技术进展令博主基本面看好。
CW（连续波）激光器瓶颈持续存在。 -> 2家晶圆厂（Win + 另一主要玩家）为 $SIVE 提供大量产能 -> $JBL 明确的爬坡时间表 - 6家新的可插拔光模块厂商处于评估/后期讨论阶段，带来近期机会 -> $GFS, Ayar, $POET, (可能包括 Celestial + 其他 CPO 共封装光学玩家)。 -> 甚至未包含他们与 TFLN 等其他技术合作的工作。 对此我基本面非常看好。
英文原文
Massive CW laser bottleneck ongoing. -> 2 foundries (Win + another major player) with substantial capacity for $SIVE -> $JBL clear ramp timing - 6 new pluggable players in eval/later stage disc for near term opportunities -> $GFS, Ayar, $POET, (potentially Celestial + other CPO players). -> not even including the other work they do with TFLN and others. I'm very positive fundamentally after this.
-
分析师关注超大规模客户供应链及上游瓶颈，而非争论机会管道。
@nimishx KPI 一直是一致的。它只是产能爬坡情况的指标。分析师主要关注的是其超大规模客户供应商，如 $GFS、$JBL、Ayar、$POET 以及其他可插拔/共封装光学(CPO)合作伙伴。以及它们的计划如何扩展，而 $SIVE 处于上游。这比争论机会管道意味着什么更有意义。
英文原文
@nimishx KPI has always been the consistent. It's just an indicator of how things would ramp. Main thing analysts look at are their hyperscaler suppliers like $GFS, $JBL, Ayar, $POET, and other pluggable/CPO partners. And how their programs scale, with $SIVE sitting upstream. Rather than trying to argue with what opportunity pipelines mean.
-
澄清对AAOI的看多立场，虽不满其ATM融资时机但认可其产能瓶颈逻辑。
关于$6亿自动取款机(ATM)融资，到处都有误读。我依然看多$AAOI，且持仓较重（所以我更在意）。 我一直坚持的观点是：不喜欢过度使用ATM/稀释股权进行融资。此前在$IREN和$POET上我也这么说过。 我会对自己的持仓如AOI保持一致性。 然而，我超配AOI而非其他（看着你Poet）的原因是： AOI确实面临产能瓶颈，且需求可见度高。 关于时机： - AOI本应等到1.6T光模块认证完成（预计未来几周） - 本可使用高于市价的可转债等其他结构 但他们在股价从$220跌至$130时操作，且未来每次使用ATM都可能带来短期结构性抛压。 我不必支持每一个商业决策，才能继续做多。
英文原文
Lot of misinterpretations flying left and right around the $600m ATM. I'm still bullish on $AAOI and I have large positions (which is why I care more). What I've been consistent with is not being a fan of overusing ATMs/dilution for financing. I've said this before with $IREN + $POET. And I'll be consistent with my own positions like AOI. However, the reason I'm still overweight on AOI vs. the rest (looking at you Poet): Is that AOI is actually capacity constrained with high demand visibility. In terms of timing: - AOI should have waited until completion of 1.6T qualifications (expected in the next few weeks) - Could have used other structures like convertible notes above market prices. But they did it on the drop from $220 -> $130, and it's likely there will be short term structural overhang whenever they want to tap into it. I don't have to support every single business decision to remain long.
-
POET获Lumilens订单，但Marvell自有IP或致其被Celestial项目排除。
@tozzi21 $POET 正在向 Lumilens 供货，Lumilens 是另一家顶级前二超大规模云服务商（拥有数十亿美元客户协议）的供应商。 光宝科技 (Lite-On) 是另一家主要参与者。 我只是说，鉴于 Marvell 在 Poet 提供的同一层级拥有自己的封装/集成 IP，他们很可能被 $MRVL Celestial 设计排除在外。
英文原文
@tozzi21 $POET is supplying Lumilens, which is another top-2 hyperscaler supplier (with billions in customer agreements). Lite-On is another major player. I'm just saying they got likely designed out $MRVL Celestial since Marvell has their own packagig/intergration IP in the same layer that Poet is offering.
-
推测SK海力士CPO供应链涉及Ayar/Celestial及上游SIVE等。
既然大家都在愉快地猜测 $SKHY 共封装光学(CPO) 路线图供应链。 我来猜一下：SK 海力士正在评估 Celestial/Ayar。随后将重点评估第一代部署后的 microLEDs（微发光二极管）。 这两家公司其实已经在这方面工作了一段时间。 - Ayar 出现在 SK 海力士官网上，语境是光 <-> 内存链接。 - Marvell 正积极与 SK 海力士合作定制内存解决方案（猜猜现在谁拥有 Celestial）。 Celestial/Ayar 也被 SK 海力士链接的 Nature 论文引用，这在技术相关性上提供了一些佐证： (121): Stojanovic, V. A UCIe optical I/O retimer chiplet for AI scale-up... 这是 Ayar 的引用（Ayar 的 teraphy 光 I/O 芯片组），顺便提一下 Stojanovic 是 Ayar Lab 的联合创始人。 (123): Winterbottom, P. Photonic interconnect for accelerated computing celestial AI photonic fabric module (咳咳，Celestial) 还有更多线索，但我想保持篇幅简短。 关于更多上游受益者： -> 我仍然认为 $SIVE 是最清晰的受益标的，因为他们很可能同时供应给 Celestial/Ayar。 中介层/封装 IP 层... 人们曾猜测 $POET，但 Marvell 可能在宣布后今年就通过垂直整合将他们淘汰了。 鉴于他们在 Celestial 被收购前就拥有自己的 SiPH 中介层技术/集成 IP（例如 2023 年展示过硅光中介层） -> AMS Osram（我不持有），看起来他们正在这一领域共同开发，因为他们今年特意指出 HBM <-> 光学对他们来说是一个 TAM（总可服务市场）增长点。 TLDR：我认为 Ayar/Celestial 是 SK 海力士 CPO 路线图的候选者，然后 microLEDs 可能在 2029 年左右实现第一代后的商业化。（这纯属猜测） 顺便给量子点粉丝一点甜头，这篇论文引用了它 5 次。
英文原文
Since people are having fun speculating on $SKHY CPO roadmap supply chains. I'm gonna do my own guess and say SK Hynix is evaluating Celestial/Ayar. Then doing heavy evaluation into microLEDs past first-gen deployments. Both have been kinda working on it for awhile. - Ayar shown up in SK hynix's own website in the context of optical <-> memory links. - Marvell is actively working with SK Hynix in custom memory solutions (and guess who owns Celestial now). Celestial/Ayar are both also cited in SK Hynix's linked Nature Paper, which helps a bit with technical relevance: (121): Stojanovic, V. A UCIe optical I/O retimer chiplet for AI scale-up. In 2025 IEEE Hot Chips 37 Symposium (HCS) 1–22 (IEEE, 2025) - This is Ayar reference (Ayar’s teraphy optical I/O chiplet), Stojanovic is Ayar Lab's co-founder btw. (123): Winterbottom, P. Photonic interconnect for accelerated computing celestial AI photonic fabric module (cough cough Celestial) There's more breadcrumbs out there, but wanted to keep this relatively short-form. For more upstream beneficaries: -> I still think $SIVE is the cleanest read through since they're likely supplying to both Celestial/Ayar. The interposer/packaging IP layer... People were speculating $POET, but Marvell probably vertically integrated players them out this year after the announcement. Given they've had their own SiPH interposer tech/integration IP before Celestials acquisition (eg. presented a silicon-photonics interposer back in 2023) -> AMS Osram (which I don't own), seems like they're co-developing in this area given they randomly went out of their way this year to say HBM <-> optics was a TAM increase for them. TLDR: I see Ayar/Celestial as candidates for SK Hynix's CPO roadmap, then microLEDs being commercialized past gen-1 maybe 2029. (this is all speculation) Just to throw a bone to quantum dot bros, this got cited like 5 times.
-
看好 $SIVE 作为高贝塔光通信标的，受益于激光器瓶颈及潜在并购。
@Blazedsin 是的，$SIVE 是我首选的高贝塔（High-Beta）光通信多头标的。 这是一家小型公司，为以下领域供应激光器： - 像 $JBL 这样提供可插拔模块的可插拔模块供应商。 - 与 $POET / O-Net 合作的外部光引擎（ELS）+ 光引擎。 - 与 Ayar 等公司合作的光 I/O 扩展。 - 像 $GFS 这样的光子代工（Photonic Foundries），涵盖 NPO/可插拔/CPO 等所有架构。 随着 Win Semi 的独立连续波（CW）产能投产，正值结构性瓶颈期……纳斯达克上市可能在接下来几个季度实现。 而且 CEO 确实懂行 + 与股东利益一致（在二级市场买入股票），稀释程度低就能完成这一切。 他们还暗示了并购（M&A），这对总可寻址市场（TAM）扩张很理想（看看 2023 年下半年 Cloud Light 并购 Lumentum 后发生了什么）。 然后你有 $MTSI，$AAOI 可能不会实质性参与第一代共封装光学（CPO）部署（参与者池较小）……行业目前面临连续波（CW）短缺，随后才是量产爬坡。针对中国竞争的监管顺风。 我不确定是不是只有我觉得，他们拥有理想的布局，主要缺点是仅在某个小型瑞典交易所上市，这损害了估值。
英文原文
@Blazedsin Yeah, $SIVE is my favorite high-beta optical long. You have a small company supplying lasers for: - Hyperscaler suppliers like $JBL with pluggables. - ELS + optical engines with $POET / O-Net. - Scale up with optical I/O with Ayar and others. - Photonic Foundries like $GFS across all architectures like NPO/pluggables/CPO. with independent CW capacity coming online with Win Semi during a structural bottleneck... NASDAQ listing likely in the next few quarters. And the CEO actually knows what he's doing + aligned with shareholders (in terms of buying stock on the open market), with low dilution to get all of this done. And they hinted at M&A, which is ideal for TAM expansion (look at what happened with Lumentum after Cloud Light H2 2023 M&A). Then you have $MTSI, $AAOI likely no meaningful participating in first-gen CPO deployments (smaller pool of players)... Industry CW shortages currently before volume ramp. Regulation tailwinds targeting Chinese competition. I'm not sure if it's just me but they have the ideal setup, main downside is that it's just listed on some small Swedish exchange and that harms valuations.
-
AI半导体板块分化，光学股复苏节奏各异，预期风险偏好回升将带动反弹。
@pkcapital_ 从 $AVGO 到 $TSM 来看，AI 半导体主题(AI semi theme)正在下跌。高贝塔(higher beta)个股似乎受到的打击最重。从我观察到的光学(optical)个股趋势来看，$LITE / $COHR 恢复最快，其次是规模更大但仍属高贝塔的个股如 $AAOI / $AXTI（恢复了一半）。而像 $SIVE / $POET 这类个股耗时最长。但我认为，当市场风险偏好(risk-on)回升或财报(earnings)推动重新评级(re-ratings)时，会出现更强劲的反弹。
英文原文
@pkcapital_ The AI semi theme is down if you look at $AVGO to $TSM. Higher beta names seem to have been hit the hardest. From trends I've seen with optical names, $LITE / $COHR recovered fastest, then larger still high beta names like $AAOI / $AXTI (halfway). Then your $SIVE / $POET type names have taken the longest. But I do see a sharper recovery when markets are more risk-on or when earnings forces re-ratings.
-
POET获230万新订单，需等财报电话会确认。
@Papsytwinz 嗯，除了 $POET 新增的 230 万美元采购订单外，没什么特别有趣的消息。需要等待财报电话会议。
英文原文
@Papsytwinz Uhh nothing really too interesting aside from a new $2.3M purchase order for $POET Will need to wait for earnings call.
-
博主说明研究发布习惯及持仓披露规则。
@dra99aso 我通常随着新消息发布（例如 Lumilens $55 亿估值公告 + 超大规模云厂商合同）沿途发布研究。但如果我像对 $POET 或 $SMCI 那样早先持有头寸，我会将其放入披露中。也许稍后我会做一个总结 TLDR。
英文原文
@dra99aso I usually just post research along the way as new news comes out (eg. Lumilens $5.5B valuation announcement + hyperscaler contracts). But I'll drop it in disclosures if I have a position on something like $POET or $SMCI earlier. Maybe I'll do a roundup TLDR later.
-
分析SIVE、AAOI、POET三股在营收、产能及客户方面的不同瓶颈。
@SammmXBT 如果非要分类的话： $SIVE = 等待营收转化 大量超大规模云计算供应商 + 对 CW DFB（分布式反馈激光器）的需求可见性。市场希望如何为等待 2027 年上半年 1.6T 升级至 2027 年下半年 共封装光学(CPO) 规模化这一过程定价或赋予溢价？ $AAOI = 等待产能执行 对光模块的需求可见性极高。他们能否提升产能以满足每月 4.71 亿美元的预测？ $POET = 等待客户 相对于市值现金过多 + 供应链产能建设资金充足，但需求可见性很低。
英文原文
@SammmXBT If I had to categorize it: $SIVE = Waiting for Revenue Conversion Tons of hyperscaler suppliers + demand visibility for the CW DFB. How do markets want to price in or assign a premium on the waiting game for 1.6T H1 2027 to CPO scale up for H2 2027? $AAOI = Waiting for Capacity Execution Extreme demand visibility for transceivers. Can they ramp up capacity to meet their $471m/month projections? $POET = Waiting for Customers Too much cash relative to MC + heavily funded supply chain capacity setup, little demand visbility.
-
分析$POET高现金低EV及产能风险，认为其技术壁垒弱于$SIVE，属高风险博弈。
好吧，这是我的 $POET 观点，毕竟子版块里有人因为我建了小仓位而在庆祝。 - 我完全没头绪。真的零头绪。他们是怎么说服股东允许他们如此大幅稀释股权，以至于： 他们现在手头有荒谬的 ~8.3 亿美元现金。 而且我猜他们快完工了，因为如果还需要更多资金，我会难以置信。 所以现在……他们有 ~8.3 亿美元用于通过并购(M&A)等业务扩张，且企业价值(EV)最近真的降得很低（例如：12.5 亿美元市值 vs. 8.3 亿美元现金在手），我认为这值得冒个险。 - 2027 年年度产能目标为 1200 万台光学引擎，这个爬坡速度相当离谱。 需要深入研究 Poet 产品的平均售价(ASP)，但可能在 $125-$200？所以按 ~$150 ASP 算，收入天花板约 18 亿美元。 但他们现在有点像反向的 AAOI：没有可见的需求来填满所有产能。除了 Lumilens，它现在是一家估值很高的超大规模供应商（可能是亚马逊或微软），拥有数十亿美元的客户协议。 有趣的是，如果 Poet 利用资产负债表与三菱等玩家签署了预付 EML 协议，或与 Sivers 签署了 CW 协议。 鉴于当前的瓶颈，玩家可能会利用 Poet 作为采购供应的变通方案。 但基本上，你拥有一家超级现金充裕、大量产能即将上线的公司。而且凭借他们的财务状况，他们不会很快消失。 我不太认为其技术护城河能像上游激光瓶颈那样具有防御性，比如 $SIVE 在 CW 激光器与 OE 封装方面的技术壁垒。正如你最近看到的 Celestial 和 Poet 的情况。 但也许……未来某个时候会有超大规模企业或下游公司宣布批量协议，$POET 随之起飞。而且他们确实具备爬坡的供应链布局。 这是我最终承担的风险，但它不像 $AAOI 那样对我来说是显而易见的长期看好。
英文原文
Okay here's my take on $POET, since apparently people are celebrating on the subreddit that I took small positions. - I have 0 idea. ZERO. How they convinced shareholders to allow them dilute SO MUCH to the point: They have an absurd ~$830m cash on hand now. And my guess is that they're close to done, since I would be in disbelief if they needed more. So now... they have ~$830m to grow their business like M&A, and EV actually dropped really low recently (eg. $1.25B MC vs. $830m cash on hand), that I thought it was compelling to take a risk. - Annualized production capacity target is 12M optical engines/year for 2027, which is pretty absurd ramp. Need to do more research into ASP for Poet's products, but maybe $125-$200? So at ~$150 ASP, $1.8B revenue ceiling. But they're like inverse AAOI right now: no visible demand to fill all that capacity. Aside from Lumilens, which is now a highly valued hyperscaler supplier (probably Amazon or Microsoft), with billions in customer agreements. The interesting thing is if Poet signed prepayment EML agreements with players like Mitsubishi, or CW agreements with Sivers behind the scenes with that balance sheet. And given the current bottleneck, players might use Poet as a workaround for supply procurement. But basically, you have a super cash-rich company with a ton of capacity coming online. And they're not really disappearing anytime soon with their financials. I don't quite think it's as technically defensible compared to upstream laser chokepoints with something like $SIVE around the same valuation in terms of technical moat for CW lasers vs. OE packaging side. As you've seen recently with Celestial and Poet. But maybe... there's a chance some hyperscaler or downstream company announces a volume agreement sometime in the future. and $POET takes off. And they do have the supply chain setup for ramp with that. That's the risk I ended up taking, but it's not exactly a clear as day long for me like $AAOI.
-
COHR财报揭示InP激光器产能紧缺，CPO需求提前，收入高增。
我的主要观点是：商用连续波(CW)激光器供应商现在显得极其重要。 但 $COHR 财报的 TLDR（太长不看版）是： “鉴于我们在数据中心业务中看到的收发器需求，我认为在可预见的未来，我们都不会对外销售磷化铟(InP)激光器。” - 如果 $AAOI 无法为第一代共封装光学(CPO)部署提供足够产能，且 $COHR 不对外销售，那么那些对外销售 InP 激光器的公司将获得更高的估值。 我想这就是为什么 $MTSI 表示大量客户正迫切地向他们寻求 InP CW DFB 激光器（而他们直到 2027 年底才没有有意义的产能上线）。 $AAOI -> 内部自用 $COHR -> 内部自用 买家 -> 寻找产能的选择更少。 “我们的积压订单现已延伸至 2027 财年，基本上已完全预订。我们实际上已预订至 2027 日历年末。” [巨大的需求可见性] - Coherent 还提到了跨越至本十年末的长期协议(LTA)。这在一定程度上印证了 $POET CEO 在其年度股东大会上所说的“三大巨头”未来两年已完全售罄。 “我们目前在组装和测试产能方面并不受限。我们真正受限的是磷化铟生产的爬坡。” - 对于那些关注瓶颈的兄弟们来说，组装/测试并不是瓶颈。 “CPO 需求绝对没有推迟。事实上，情况恰恰相反。我们看到了需求增加，客户的要求被提前。” “我们继续预计来自规模化应用的 CPO 收入将从 2027 年日历年下半年开始流入。” - 如果 $LITE 和 $COHR 确认 CPO 规模化收入将在 2027 年下半年到来，这对其他 CPO 参与者来说是一个巨大的利好传导。 - “到 2027 财年末，季度收入超过 30 亿美元” - $COHR 收入飞速增长 所以常规数据如下： - 收入 20.46 亿美元（环比 +13.3%，同比 +33.8%），主要收入增长看起来发生在进入 Q4 至 2027 年期间 - 非公认会计准则毛利率：40.2% 下一季度指引为： - 收入：22-24 亿美元 - 非公认会计准则毛利率：39.5-41.5% 基本上： 16.9 亿 -> 18.1 亿 -> 20.5 亿 -> ~23.0 亿 -> 30 亿（2027 财年末） ~39% -> 39.6% -> 40.2% -> ~40.5%（毛利率） 对于营业利润率： 18.0% -> 19.5% -> 19.9% -> 20.3% -> 21.8% 与 $LITE 的利润率增长相比，我对盈利能力的印象稍逊一筹，但 $COHR 的收入规模正在快速增长。
英文原文
My main takeaway was that your merchant CW laser suppliers seem to be EXTREMELY IMPORTANT now. But TLDR of $COHR earnings: "given the demand that we see in our DC business with transceivers, I don’t see any time in the near future where we would be selling indium phosphide lasers externally" - Ton more value placed on companies that sell InP lasers externally if $AAOI can't doesn't enough capacity for first gen-CPO deployments, $COHR not selling externally... I guess that's why $MTSI said a ton of customers are approaching them with urgency for InP CW DFB lasers (and they dont even have meaningful capacity coming online until EOY 2027) $AAOI -> Internal $COHR -> Internal Buyers -> fewer places to look for capacity. "Our backlog now extends out, fiscal 2027 is basically completely booked out. We are booked really through the end of calendar 2027" [ Massive massive demand visibility] - Coherent also mentioned LTAs spanning end of decade. So this kinda reinforces what $POET CEO said at their AGM that the "big 3" are fully sold out next 2 years. "we’re not constrained in the assembly and test capacity right now. We’re really just constrained by the ramp of the indium phosphide production" - Just for the bottleneck bros in terms of assembly/test not a bottleneck. "absolutely no push-out of CPO demand. In fact, it has been the opposite. We have seen demand increase and request from customers’ demand getting pulled in" "we continue to expect revenue from CPO for scale-up applications to start to flow in the second half of calendar 2027" - Big read through on other CPO players for scale up if $LITE, $COHR reaffirm revenue from CPO scale up coming h2027. - "quarterly revenue exceeding $3 billion by the end of fiscal 2027" - $COHR revenue go brrr So for regular numbers it's: - $2.046B revenue (+13.3% Q/Q, +33.8% Y/Y), main revenue ramp looks to be happening entering Q4 into 2027 - Non-GAAP gross margins: 40.2% Next quarter guide is: - Revenue: $2.2–$2.4B revenue - Non-GAAP gross margins: 39.5-41.5% Basically: $1.69B -> $1.81B -> $2.05B -> ~$2.30B -> $3.0B (end of FY 2027) ~39% -> 39.6% -> 40.2% -> ~40.5% (gross margins) For operating margins: 18.0% -> 19.5% -> 19.9% -> 20.3% -> 21.8% Little less impressed compared to $LITE margin growth in terms of profitability, but revenue scale for $COHR growing rapidly.
-
反驳对SIVE的质疑，强调其IP模式独特性及在CPO领域的长期潜力。
@Malinrec - 因为新一代 1.6T 光收发器(1.6T optical transceivers)和共封装光学(CPO)的出货量尚未爬坡。$SIVE 正瞄准所有下一代光学变革。 这源于对架构转变的误解，如果客户 CPO 的大规模部署始于 2028 年，你不可能在 2024 年获得 9 位数收入。 - $SIVE 拥有 130 多名员工，如果我没记错，其中 1/4 到 1/3 是博士。 他们做的很多是知识产权(IP)，并使用 Win Semi 和外部晶圆厂进行量产爬坡。如果他们像 $FN 或 $COHR 那样做组装，你会看到员工数量激增。 不太明白为什么你说一个向 $JBL、$GFS、Ayar、$POET 和许多其他超大规模供应商供货的客户是毫无希望的案例。 这可能是我见过的最独特的案例之一。
英文原文
@Malinrec - Because newer 1.6T optical transceivers and CPO volumes haven't ramped yet. $SIVE is targeting all the next generation optical shifts. This comes from a misunderstanding of architectural shifts, you won't get 9 figure revenue in 2024 if customer CPO scale up deployments start in 2028. - $SIVE has 130+ employees and if I remember correctly, 1/4th to 1/3d were PHDs. Lot of what they do is IP and they use Win Semi, external foundries for volume ramp. If they did assembly like $FN or $COHR, you would see employee count balloon. Not quite sure why you say a customer supplying to $JBL, $GFS, Ayar, $POET, and many other hyperscaler suppliers is a hopeless case. Probably one of the most unique ones I've seen.
-
博主坦言对采用率细节不熟，难以评估对POET等竞对的影响。
@NicolaRussoIT 我对采用率的具体细节不太熟悉，虽然浏览过 $ANET、$XPO 和 $MSA 的资料（我知道 $MSFT 是最公开表示支持的）……所以很难对 $POET 等其他参与者的影响给出很好的回答。https://t.co/Xi6zrmo5ha
英文原文
@NicolaRussoIT Not as familiar with adoption read through with $ANET XPO MSA (ik $MSFT has been the most openly supportive).. so can't really give a good answer to implications on other players like $POET. https://t.co/Xi6zrmo5ha
-
光模块供需失衡且产能售罄，预计LITE财报强劲并作为行业风向标。
@00m00oo 我认为从 $AAOI 的财报中我们已经得到了太多关于光模块(Optical Transceivers)需求存在20-40%失衡以及激光器(Lasers)成为瓶颈的暗示。 而且 $POET 在其年度股东大会(AGM)上表示，未来两年三大云厂商的产能已完全售罄。 我通常不做财报涨跌预测，因为那大多时候就像抛硬币一样随机。但我可以说，除非有非常意外的情况，否则大部分定价调整在财报发布前就已经发生。 无论如何，我预计 $LITE 的财报会非常强劲，我主要将其作为其他激光器厂商的参考指标(read-through)。
英文原文
@00m00oo I think we already got too many hints from $AAOI earnings about demand 20-40% imbalance for optical transivers with lasers as a bottleneck. And $POET stating big 3 are completely sold out of capacity next 2 years during their AGM. I don’t give earnings up or down predictions since it’s a coin flip most of the time. But I can say that a lot of pricing happens before earnings, unless there’s something very unexpected. Regardless I expect $LITE earnings to come out really strong, and I primary use it as a read through for your other laser players.
-
看好SIVE获代工产能及上市融资，预期2027H1收入拐点。
@wannabepanacea 鉴于目前业界普遍传闻共封装光学(CPO)中的分布式反馈激光器(DFB)短缺，我其实挺好奇 $SIVE 能否获得更多晶圆代工产能分配。因为我相当确信，一旦其资格认证进入量产爬坡阶段，产品就会售罄。除此之外： > 其他财报（如 $MTSI / $AAOI）重申的需求/供应失衡有助于佐证这一点。 > 上一份财报中提到的与可插拔(Pluggable)玩家的新进展/资格认证，可能是影响最大的因素。 > 与 $JBL、~ $AEVA、$POET、$GFS 或其他机会的进展，如果能获得初步采购订单(PO)那就太好了。 > 重申纳斯达克上市更新（我们已经得到消息，计划在未来几个季度完成）。我个人仍将此列为优先事项，因为它能为其并购(M&A)活动解锁更多资金，希望用于可插拔技术栈。 我认为收入拐点大约在 2027 年上半年开始，因此当前的收入/利润数据并不重要。 如果 $AAOI 能发表类似“我们制造的任何东西都预计在 2028 年售罄”的声明，那就太棒了。
英文原文
@wannabepanacea I’m actually kinda curious about $SIVE securing more foundry allocation given widespread CW DFB shortages now. Since I’m pretty confident it sells out once qualifications go into volume ramp. But aside from that > reaffirm demand/supply imbalance from other earnings like $MTSI / $AAOI helps > new development/qualifications mentioned in previous earnings with pluggable players, probably most material > Progress with $JBL, ~ $AEVA, $POET, $GFS or other opportunities, maybe initial POs would be nice. > Nasdaq listing update reiterated (we already got updates it’s planned completion next few quarters). I still place that on priority personally since it unlocks more funding for their M&A efforts, hopefully down the pluggable stack. I think the revenue inflection starts around H1 2027, so current revenue/profit numbers are not very material. An $AAOI statement like anything we make we expect to be sold in 2028 or something would be kinda goated.
-
Lumilens高估值确认光互连上游POET/SIVE价值，博主加仓POET。
今天早些时候，光互连公司 Lumilens 以 55 亿美元估值“结束隐身模式”，此前已融资 7 亿美元。 正如我之前分享的 $POET / $SIVE LinkedIn OSINT 映射回顾，Lumilens 正在为一家前三超大规模云服务商客户供货。 因此，一个月后我们确认了这一点，并得知 Lumilens 拥有“数十亿美元的客户协议”。 仅供参考，$POET 与 Lumilens 有现有合同（5000 万美元采购订单，最高 5 亿美元）+ 与 $SIVE 的合同（取决于产品线）。 在阅读此新闻后，我再次在 POET 上建立了少量头寸，因为它终于让他们看到了资金极其充裕的超大规模云服务商供应商（加上 Poet 非常庞大的资产负债表）。 但简而言之： > Lumilens 估值与 Lightmatter/Ayar 相当（甚至更高），拥有超大规模云服务商客户，规模比市场预期的要大。 > 对上游 $POET（去风险化）/ $SIVE 的利好传导。 > 对光互连估值整体有利，看到一家公司在 2 年内达到 55 亿美元。
英文原文
Earlier today, optical interconnect company Lumilens "emerges from stealth" at a $5.5B valuation, after raising $700m. Just as a recap from $POET / $SIVE Linkedin OSINT mapping I shared earlier, Lumilens was supplying a top 3 hyperscaler customer. So we got confirmation of that a month later, along with the material figure that Lumilens has a "multi-billion-dollar customer agreement". And just for reference, $POET has existing contracts with Lumilens ($50m purchase order, up to $500m) + contracts with $SIVE (depending on product lines). I actually took tiny positions in POET again after reading this news, since it finally gives them visibility into extremely well funded hyperscaler suppliers (on top of Poet's really large balance sheet). But TLDR: > Lumilens around similar (or even higher) valuations as Lightmatter/Ayar, bigger than markets thought with hyperscaler customers. > nice read through upstream on $POET (derisking) / $SIVE. > Great for optical valuations in general, seeing a company go to $5.5B in 2 years.
-
POET与Sivers合作加速，2027H1订单落地，验证CPO等新技术拐点临近。
仔细想想，$POET 的光学中介层（optical interposer）业务与 $SIVE 的关联比我想象的更重要。起初措辞是2026年底的“准备就绪”，但 $POET 将其升级为与 Sivers 激光器合作的“量产”，预计2026年底实现。因此，从 $JBL 到 $POET 的批量订单应在2027年上半年落地。这很合理，因为 Sivers 已完成超认购的机构轮融资以支持未来大规模生产。顺便一提，难以置信已是八月，距2027年仅剩5个月……这是我预判玻璃基板、共封装光学(CPO)、800V 及新架构开始放量的拐点窗口。
英文原文
Now that I think of it more, $POET optical interposer piece is actually a little more material than I thought with $SIVE. Originally the wording was "readiness" for EOY 2026. But $POET upgraded that wording, by stating "production" with Sivers lasers projected EOY 2026. So a volume orders from across $JBL to $POET, should hit in H1 2027. Which makes a bit of sense, since Sivers did raise an institutional oversubscribed round for future mass production. On a side note, can't believe it's already August and 5 months left until 2027... Which was my inflection window for glass substrates, CPO, 800v, and new architectures to ramp.
-
POET光学中介层进展升级，Sivers从准备就绪迈向2026年底量产。
@A22GEO $POET 的光学中介层（optical interposer）部分其实是一个非常有趣的更新，并谈到了 $SIVE。因为对于 Sivers 和 Poet 来说，这是关于 2026 年底“生产”（production）的时间表措辞升级。回想 Sivers 发布新闻稿时，用的词是“生产准备就绪”（production readiness）。
英文原文
@A22GEO The $POET optical interposer piece is actually a very interesting update and talks about $SIVE. Since it's a material timeline upgrade wording for "production" EOY 2026, for Sivers + Poet. Back when Sivers did their PR it was "production readiness" https://t.co/EHkOogR39K
-
博主认为当前估值极具吸引力，重申AAOI和NBIS的营收拐点预期。
@WangHou4128 我不认为我（或任何人）能准确预测底部。否则如果他们真知道，早就做每周期权了。 不过很难想象某些标的会跌得更低，比如 $AAOI 的市值已接近1倍年化远期营收。$POET 跌幅巨大，其市值约10.8亿美元，而现金就有约8亿美元。 总体而言，即使 Leopond 也认为当前估值极具吸引力，所以他正在募资买入下跌。不过谁说得准呢？ 但从中长期来看，就我个人的投资逻辑而言，我预计一旦营收预测兑现为盈利，行情就会展开。 我重申 $AAOI 的营收拐点在2027年上半年末……$NBIS 的营收拐点在2026年第四季度，等等，这是我的个人估算。 当然，在此之前会有大量波动。
英文原文
@WangHou4128 I don't think I (or anyone else) can accurately call the bottom. Otherwise they would just do weekly options if they knew. It's hard to see some of the names drop any lower though, like $AAOI is close to 1x annualized fwd revenue/MC. $POET dropped so much that it's roughly ~$800m cash to $1.08B MC. In general, even Leopond finds current valuations extremely attractive, so he's raising more to buy the drop. Who knows though? But medium-long term, for my own thesis, I expect them to play out once revenue projections hit earnings. I've reiterated end of H1 2027 for $AAOI in terms of revenue inflection.... H4 2026 for $NBIS revenue inflection, and so on for my own ests. Of course, lot of volatility in between then.
-
SIVE轻晶圆厂产能模型显示高毛利潜力，CW瓶颈加剧利好，看好其CPO地位及并购上行空间。
很多人对 $SIVE 通过轻晶圆厂模式（Win Semi 等）进行产能爬坡建模感到好奇： 假设使用 Win 10% 的晶圆产能作为低端配置（65% 良率假设，$50-$75 ASP）： Sivers 将支撑 $3.41 亿-$5.12 亿的年度阵列营收。鉴于管理层 50-60%+ 毛利率目标的上限，大致为： $2.05 亿-$3.07 亿的年度毛利润。 相对于 Sivers 当前约 $11 亿的市场资本化，若此产能情景在 2028 年实现，约为： 3.6–5.4 倍 市值/毛利润。 若按 15% 计算，毛利润为 $3.07 亿-$4.61 亿（2.4–3.6 倍 市值/毛利润）。 Sivers CEO 也回复称他们正在与更多晶圆厂合作以获取产能。从旧版演示文稿看，自 2024 年以来似乎有更多的资格认证。 因此，随着共封装光学(CPO) 的兴起，产能目标可能比此处陈述的更大。 我也预计未来季度营收管道预测将上调，因为更多合格供应商进入大规模量产(HVM)。 _ 至于需求端，连续波(CW) 激光器也非常瓶颈。 Lumentum 因 ER 财报电话会议中的外延面激光二极管(EML) 义务，正在公开市场购买 CW 激光器。 $AMD 正在签署长期协议(LTA) 以锁定 CW 产能（来自 Trendforce）。所以当 Sivers 与 $GFS, $JBL, Ayar, $POET, O-NET 等合作爬坡时... 鉴于当前的限制，任何上线的独立合格产能很可能被吸收。 锦上添花的是，摩根士丹利将 $SIVE (~$11 亿) 列为三大领先 CPO 激光器玩家之一。 与其近期笔记中 $550 亿+ 的 Coherent 和 Lumentum 并列，是有原因的... _ 总结：Sivers 仅需 Win 的低端配置，相对于当前估值即可产生可观的毛利润。 我认为最大的未建模营收上行空间在于美国纳斯达克上市后的 TAM 扩张与并购。 通过复制 Lumentum 与 Cloud Light 的剧本，构建整个收发器模块或光引擎。
英文原文
Lot of people were curious about $SIVE capacity volume ramp modeling through fab-light (Win Semi + others): Using 10% of Win's wafer capacity as a low-end allocation (65% yield assumption, $50-$75 ASP): Sivers would support $341-$512M worth of annual array revenue. Given upper end of managements 50-60%+ gross margin target, would be roughly: $205–307M of annual gross profit. Against Sivers current ~$1.1B MC, would be ~: 3.6–5.4× MC/gross profit if this capacity scenario plays out in 2028. And at 15% would be $307–461M in gross profit (2.4–3.6× MC/gross profit) Sivers CEO also replied that they're working with more fabs for capacity. And from an older deck, there looks to be more qualifications since 2024. So capacity targets might be larger than what's stated here as CPO takes off. I also expect to see revenue pipeline projections hiked in future quarters, as more qualification suppliers to into HVM. _ As for demand side, CW also happens to be very bottlenecked. Lumentum are buying CW off the open market due to EML obligations from their ER transcript. And $AMD are signing LTAs to secure CW capacity (from Trendforce). So when Sivers is ramping with $GFS, $JBL, Ayar, $POET, O-NET and others... Given the current constraints, it's highly likely any independent qualified capacity that comes online would be absorbed. And as a cherry on top, Morgan Stanley named $SIVE (~$1.1B) as one of the three leading CPO laser players . Alongside $55B+ players Coherent and Lumentum in their recent note for a reason... _ TLDR: Sivers only needs a low end allocation from Win to make substantial gross income relative to current valuations. I think the largest revenue upside that isn't modeled in if they TAM expansion with M&A after US NASDAQ listing. By copying the Lumentum playbook with Cloud Light to build out entire transceiver modules or with optical engines.
-
POET证实光学巨头遭抛售，预示市场将经历去杠杆回调。
@meikozz_2026 我认为基本面没有错。市场可能会不时出现大幅回调，以清洗掉杠杆和保证金，随后才会继续上涨。 而且这个月似乎就是这样的时间节点？ $POET 证实你们提到的大型光学巨头如 $LITE、$COHR 已被完全抛售。
英文原文
@meikozz_2026 I don't see any fundamentally wrong. There's probably going to be large corrections from time to time flush out margin/leverage before things move higher. And this month seems like that time of year? $POET confirmed your big optical giants like $LITE, $COHR are completely sold
-
看好$SIVE，因其作为激光供应商地位稳固且计划上市并购。
@FaceHonor $SIVE 大概是我目前最看好的股票，我不担心短期下跌。 - 你是 $GFS、$JBL、Ayar、$POET 以及许多其他超大规模客户供应商的激光供应商。 - 计划在未来几个季度在纳斯达克上市。 - 随后将通过并购(M&A)目标来扩大总可服务市场(TAM)。
英文原文
@FaceHonor $SIVE is probably my favorite stocks right now, not concerned about short term drops. - You have the laser supplier to $GFS, $JBL, Ayar, $POET, and many other hyperscaler suppliers. - NASDAQ listing planned in the next few quarters - Followed by M&A goals for TAM expansion.
-
SIVE获7000万扩产，多家公司产量爬坡，无视技术面噪音。
@Cped221267 没人应该关心技术分析(TA)图表，因为那只是人们编造出来的曲线，试图说服别人卖出。 $SIVE 刚刚紧急筹集了 7000 万美元，用于大规模量产，很可能是为了从晶圆厂(Foundry)获取产能分配。 随着 $JBL、$POET、$AEVA 等公司在短期内产量爬坡。 然后是 $GFS，
英文原文
@Cped221267 Nobody should care about TA charts since people just made up squiggly lines trying to convince others to sell. $SIVE just raised an emergency $70M for mass production likely for allocation from fabs. With $JBL, $POET, $AEVA, and others volume ramping near term. Then $GFS,
-
光子学营收扎实且获NVDA支持，LITE订单饱满，量子计算营收寥寥。
光子学有实际营收数据支撑，且是 $NVDA 推崇的架构变革。 量子计算几乎没有营收。 $LITE 未来两年订单已完全售罄（据 $POET 股东大会），预计从 2029 年开始交付。Lumentum 产能极度紧张，甚至需要外购 CW 激光器。
英文原文
Photonics is backed by actual revenue numbers and it's an architectural shift championed by $NVDA. Quantum barely has any revenue. $LITE is completely sold out for the next 2 years (per $POET AGM) likely starting into 2029. Lumentum is so strained that they buy CW lasers off
-
POET 暗示激光器短缺将延续至 2029 年，加剧供应紧张。
关于 $POET 年度股东大会及光通信市场阅读的一些笔记： - “前三大激光器供应商占据 68% 的市场份额，且未来两年完全售罄” $LITE 首席执行官表示短缺将持续至 2028 年，因此 POET 隐含确认激光器短缺将延续至 2029 年。 - https://t.co/Lx8IHQ9fyK
英文原文
Just some notes on $POET AGM and read through on optical markets: - "The top three laser suppliers control 68% of the market, and they’re completely sold out for the next two years" $LITE CEO said into 2028, so POET implicitly confirms laser shortage is going into 2029 now. - https://t.co/Lx8IHQ9fyK
-
博主澄清对SIVE极度看好，列举其CPO及高速光模块业务优势。
哦，我觉得你误解了……随着价格下跌，我实际上比以往任何时候都更看好。$SIVE 市值约 19 亿美元，你拥有：- $GFS 参考激光器 - 用于 Ayar 等公司在 $NVDA NVLink 生态系统中进行共封装光学(CPO)规模扩展的激光器 - $POET 等用于 CPO 规模扩展 - $JBL 等用于 1.6T+ 速率
英文原文
oh i think u misunderstand... I'm actually more bullish than ever as prices go down. $SIVE at ~$1.9B MC you have: - $GFS reference laser - laser for Ayar and others in $NVDA NVLink ecosystem for CPO scale up - $POET and others for CPO scale out - $JBL and others for 1.6T+